Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,461,345
-
Share change
-
+1,032,384
-
Total reported value
-
$21,327,053
-
Put/Call ratio
-
112%
-
Price per share
-
$3.30
-
Number of holders
-
50
-
Value change
-
+$3,398,259
-
Number of buys
-
24
-
Number of sells
-
27
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q4 2020
As of 31 Dec 2020,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,461,345 shares.
The largest 10 holders included
ETF MANAGERS GROUP, LLC, VANGUARD GROUP INC, Mirae Asset Global Investments Co., Ltd., AdvisorShares Investments LLC, BlackRock Inc., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.